Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant modified vaccinia virus Ankara expressing tuberculosis antigen 85A

EU orphan designation number: EU/3/05/318   
Active ingredient: Recombinant modified vaccinia virus Ankara expressing tuberculosis antigen 85A
Indication: Prevention of tuberculosis disease in BCG vaccinated individuals
Sponsor: University of Oxford
Wellington Square, Oxford OX1 2JD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2005 Centralised Orphan - Designation EMEA/OD/029/05 (2005)4347 of 28/10/2005
16/02/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/029/05/T/01 (2009)1066 of 12/02/2009
24/05/2013 Other procedure
21/06/2013 Centralised Orphan - Transfer of orphan designation EMEA/OD/029/05/T/02 (2013)3968 of 19/06/2013